131
Views
6
CrossRef citations to date
0
Altmetric
Articles

The clinical role of serum cell division control 42 in coronary heart disease

, ORCID Icon, , , , , , , , & show all
Pages 45-50 | Received 10 Nov 2022, Accepted 29 Dec 2022, Published online: 17 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xuechao Wang, Junjie Feng, Shaohua Luan, Yong Zhou, Shipan Zhang, Hongling Su & Zhongyu Wang. (2024) Linkage of CDC42 And T-helper Cell Ratio With Anxiety, Depression And Quality of Life in ST-Elevation Myocardial Infarction. Biomarkers in Medicine 18:5, pages 157-168.
Read now

Articles from other publishers (5)

Shaohua Luan, Lei Zhang, Xiaodan Cheng, Yuanyuan Wang, Qiang Feng, Lei Wei, Fan Jiang & Jinjun Liu. (2023) The ability and optimal cutoff value of serum cell division cycle 42 in estimating major adverse cardiac event in STEMI patients treated with percutaneous coronary intervention. Heart and Vessels 39:4, pages 277-287.
Crossref
Hongyu Yu, Jian Ma, Yueru Gu, Wei Zou & Na Zhao. (2024) Serum cell division cycle 42 reflects the development and progression of diabetic nephropathy in patients with diabetes mellitus. Experimental and Therapeutic Medicine 27:5.
Crossref
Kun Huang, Qinqin Wang, Huilong Qu, Xinyu Hu, Wenhao Niu, Anna Hultgårdh-Nilsson, Jan Nilsson, Chun Liang & Yihong Chen. (2024) Effect of acidosis on adipose-derived stem cell impairment and gene expression. Regenerative Therapy 25, pages 331-343.
Crossref
Hui Peng, Xugang Wang, Longfei Zhang, Yang Su, Jieli Yan & Xin Wu. (2024) Correlation of the serum cell division cycle 42 with CD4+ T cell subsets and in-hospital mortality in Stanford type B aortic dissection patients. Frontiers in Cardiovascular Medicine 11.
Crossref
Lei Wu, Hui Li, Huanzhen Chen, Chunyu Fan, Yan Lu, Ruipeng Wei, Guangzhao Yang & Yongping Jia. (2023) The clinical utility of circulating cell division control 42 in small-vessel coronary artery disease patients undergoing drug-coated balloon treatment. BMC Cardiovascular Disorders 23:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.